A nurse is planning a presentation to a group of nursing students on the topic of anxiety disorders. Which statement would the nurse include when describing panic disorder?

Choice A reason: Naltrexone is an opioid receptor antagonist used for the maintenance of sobriety in alcohol use disorder and as a long-term pharmacological adjunct in opioid use disorder following detoxification. It is available in oral formulation (ReVia) and as an extended-release injectable formulation (Vivitrol). Critically, naltrexone is not indicated for the acute reversal of opioid-induced respiratory depression. Its use in active opioid intoxication without full detoxification can precipitate severe opioid withdrawal. Naltrexone is a maintenance, not an emergency reversal, agent and would not be the appropriate medication in this acute overdose scenario.

Choice B reason: Varenicline (Chantix) is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor, primarily used as a smoking cessation pharmacotherapy. It reduces nicotine cravings and withdrawal symptoms by providing partial receptor stimulation while blocking nicotine binding. Varenicline has no pharmacological activity at opioid receptors and no role in the acute management of opioid toxidrome. Administering this medication in the context of acute heroin-induced respiratory depression would be clinically inappropriate and ineffective, as it does not possess opioid receptor antagonist properties.

Choice C reason: Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) used as an antidepressant and as a pharmacological aid for smoking cessation (marketed as Zyban for this indication). It acts by inhibiting the reuptake of norepinephrine and dopamine in the presynaptic terminal, thereby increasing their synaptic concentration. Bupropion has no opioid receptor activity and is not indicated in the management of acute opioid overdose. Its administration in this emergency setting would provide no clinical benefit and would delay delivery of the appropriate reversal agent.

Choice D reason: Naloxone (Narcan) is a pure opioid receptor antagonist with high affinity for mu, kappa, and delta opioid receptors. It competitively displaces opioids from their receptor sites, rapidly reversing opioid-induced respiratory depression, miosis (pinpoint pupils), and unconsciousness within 2 to 5 minutes when administered intravenously. The clinical triad of unconsciousness, slow respirations, and pinpoint pupils (miosis) described in the question is the classic presentation of acute opioid toxidrome. Naloxone is the emergency pharmacological standard of care for opioid overdose reversal and is endorsed by emergency medicine, toxicology, and nursing guidelines as the immediate life-saving intervention in this scenario.

Choice A reason: Death of a spouse is a significant psychosocial stressor and a known precipitant of complicated grief, major depressive disorder, and increased suicidal ideation in bereaved adults. However, in the specific context of an adolescent, spousal bereavement is not developmentally applicable and therefore would not be the most relevant or accurate response to a family member asking about predictive risk factors for future suicide attempts in this age group. While loss can contribute to suicidal risk, death of a spouse is not considered a primary predictive risk factor for future attempts in the adolescent population.

Choice B reason: Unemployment is a recognized psychosocial risk factor associated with increased rates of depression, hopelessness, and suicidal ideation in the adult population, particularly in middle-aged men. It is linked to financial stress, loss of identity, and social isolation. However, while employment-related stressors may contribute to overall suicidal risk in adults, unemployment is not considered the strongest or most evidence-based predictor of future suicide attempts, particularly in adolescents. A direct, validated predictor of repeat suicidal behavior has greater clinical utility in guiding risk assessment and response to a family's inquiry.

Choice C reason: A previous suicide attempt is the single most statistically robust and clinically validated predictor of future suicide attempts and completed suicide across all age groups, including adolescents. Research in suicidology consistently demonstrates that individuals with a history of prior suicide attempts are at significantly elevated risk of repeat behavior, with studies indicating that approximately 15 to 25% of individuals who have attempted suicide will make subsequent attempts. The lethality of prior attempts, method used, intent, and circumstances of rescue are additional dimensions that inform risk stratification. This information is clinically essential and directly responds to the family member's question.

Choice D reason: Polysubstance use is a well-established and clinically significant risk factor for suicidal behavior. Intoxication disinhibits impulse control, impairs judgment, increases emotional dysregulation, and can precipitate acute suicidal crises in predisposed individuals. Comorbid substance use disorders significantly elevate lifetime suicide risk. However, while polysubstance use is an important contributor to overall suicide risk and must be assessed, it does not carry the same predictive power for future suicide attempts as a previous suicide attempt itself, which is universally considered the most powerful single risk factor in validated suicide risk assessment tools such as the Columbia Suicide Severity Rating Scale (C-SSRS).